Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01040858 · ClinicalTrials.gov registry record · NA
Cognitive Rehabilitation of Operations Iraqi Freedom and Enduring Freedom (OIF/OEF) Veterans With Cognitive Disorder
A NA study of Cognition Disorders, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 128
- Enrollment target
- 4
- Study locations
NCT01040858: Completed NA study of Cognition Disorders, sponsored by US Department of Veterans Affairs.
NCT01040858 is a NA study of Cognition Disorders that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 128 participants, below the 262-participant average among 9 other Cognition Disorders trials with a reported enrollment target (51% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01040858, a NA study of Cognition Disorders, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
- 4
- Study locations
Study Summary
The number of OEF/OIF veterans seeking care and rehabilitation services within the VA Health Care System is increasing rapidly. The cognitive effects of MTBI are clinically significant and can adversely affect a veteran's ability to reintegrate into civilian life, return to duty, succeed in competitive employment, or function independently. The primary product of the proposed study would be an empirically validated, manualized, cognitive rehabilitation intervention for OIF/OIF veterans with cognitive disorders. The group treatment modality has the virtue of efficiency and a manualized treatment approach would allow wide-ranging application throughout the VHA system. As such, the proposed study is likely to have a significant effect on the quality and effectiveness of rehabilitative services being offered to our returning soldiers with combat-related MTBI and cognitive impairment.
Primary Outcome
A self-report measure of severity of attention and organizational problems. It measures the sum of severity ratings on a scale from 0 (never) to 4 (very often). The total score ranges from 0 to 64.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Strategy Training
- OTHER Placebo comparison group
Study Locations (4)
California
- VA San Diego Healthcare System, San Diego - San Diego
Idaho
- VA Medical Center, Boise - Boise
Oregon
- VA Medical Center, Portland - Portland
Washington
- VA Puget Sound Health Care System, Seattle - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2011-05 |
| Est. Completion | 2013-09 |
| Phase | NA |
What the finished NCT01040858 record still lists
NCT01040858 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 262-participant average among 9 other Cognition Disorders trials with a reported enrollment target (51% lower).
The record links to 1 condition, with Cognition Disorders appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Strategy Training is the first listed.
NCT01040858 reports a single indexed study location in California, Idaho, Oregon.
Frequently Asked Questions
What is clinical trial NCT01040858 about?
NCT01040858 is a clinical study titled "Cognitive Rehabilitation of Operations Iraqi Freedom and Enduring Freedom (OIF/OEF) Veterans With Cognitive Disorder". The number of OEF/OIF veterans seeking care and rehabilitation services within the VA Health Care System is increasing rapidly. The cognitive effects of MTBI are clinically significant and can adversely affect a veteran's ability to reintegrate into civilian life, return to duty, succeed in competit...
What is the current status of trial NCT01040858?
This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2011-05. Estimated completion is 2013-09.
What conditions does trial NCT01040858 study?
This clinical trial studies the following conditions: Cognition Disorders.
What interventions are being tested in trial NCT01040858?
The interventions under investigation include: Cognitive Strategy Training (BEHAVIORAL), Placebo comparison group (OTHER).
Who is sponsoring clinical trial NCT01040858?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01040858 being conducted?
This trial has 4 study locations across California, Idaho, Oregon, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognition Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01040858's enrollment target sits among peer trials
128 7th of 9 higher than 3 of 9 other Cognition Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cognition Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase II Early Behavioral Intervention in BMT w/ Sleep Disturbance-Assess QOL+Fatigue+Cognitive f(x)
COMPLETED · NA
-
The BRAIN Intensive Care Unit (ICU) Study: Bringing to Light the Risk Factors
ACTIVE NOT RECRUITING
-
A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS).
COMPLETED · Phase 1
-
PET Scan to Map the Areas of the Brain Involved in Planning
COMPLETED
-
Therapy for Depressed Elders With Thought Problems
COMPLETED · Phase 3
-
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02870738 · 128 participants · Phase 2
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
- NCT03294460 · 128 participants · Phase 1
Nicotinic Receptor Genetic Variation and Alcohol Reward
- NCT04149977 · 128 participants · NA
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
- NCT04373057 · 128 participants · Phase 1
Prebiotic Galacto-oligosaccharide and Acute GVHD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia